Published in Arterioscler Thromb on August 01, 1993
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet (2008) 10.87
The concept of race and health status in America. Public Health Rep (1994) 3.67
Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events. J Am Coll Cardiol (2008) 1.69
Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study. Ann Epidemiol (2007) 1.23
Established risk factors account for most of the racial differences in cardiovascular disease mortality. PLoS One (2007) 1.12
Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study. Hum Genet (2007) 1.12
Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest. PLoS One (2010) 1.09
HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study. Lung Cancer (2008) 1.06
Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women. Int J Obes (Lond) (2008) 1.06
Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population. Arterioscler Thromb Vasc Biol (2002) 1.05
Biogeographic ancestry, self-identified race, and admixture-phenotype associations in the Heart SCORE Study. Am J Epidemiol (2012) 0.92
Association analysis of 33 lipoprotein candidate genes in multi-generational families of African ancestry. J Lipid Res (2010) 0.87
Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans. J Intern Med (2008) 0.85
Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy. Vasc Health Risk Manag (2012) 0.85
Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study. Korean J Intern Med (2016) 0.81
Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study. PLoS One (2016) 0.79
An approach to the etiology of metabolic syndrome. Colomb Med (Cali) (2013) 0.77
Hypercholesterolemia and Dyslipidemia. Curr Treat Options Cardiovasc Med (2000) 0.77
Association of body mass index and abdominal adiposity with atherogenic lipid profile in Nigerians with type 2 diabetes and/or hypertension. Niger Med J (2013) 0.75
Multiple lipid scoring system for prediction of coronary heart disease risk: application to African Americans. J Natl Med Assoc (2006) 0.75
Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med (2016) 0.75
Influence of vanadium on serum lipid and lipoprotein profiles: a population-based study among vanadium exposed workers. Lipids Health Dis (2014) 0.75
The association of cell cycle checkpoint 2 variants and kidney function: findings of the Family Blood Pressure Program and the Atherosclerosis Risk In Communities study. Am J Hypertens (2009) 0.75
The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina. Glob Cardiol Sci Pract (2014) 0.75
Lipoprotein(a): a not-so-well-known risk factor for the development of cardiovascular disease in patients with type 2 diabetes mellitus. Korean J Intern Med (2016) 0.75
Analysis of angiographic trial data in women. Drugs (1994) 0.75
DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet (1998) 11.70
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
VNTR allele frequency distributions under the stepwise mutation model: a computer simulation approach. Genetics (1993) 8.22
Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet (1998) 7.56
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51
A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58
Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med (1993) 5.14
Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium. Am J Hum Genet (2000) 4.74
Assessing genetic linkage and association with robust components of variance approaches. Ann Hum Genet (1996) 4.41
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation (2001) 4.21
Plasmid transfer from Escherichia coli to Bacteroides fragilis: differential expression of antibiotic resistance phenotypes. Proc Natl Acad Sci U S A (1984) 3.85
A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett (1974) 3.43
Expression in Escherichia coli of cryptic tetracycline resistance genes from bacteroides R plasmids. Plasmid (1984) 3.19
Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med (1990) 3.17
Serum cholesterol. Doing the right thing. Circulation (1993) 3.16
Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost (1993) 3.12
The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol (1976) 3.12
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA (1994) 3.11
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation (1998) 2.88
Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am J Hum Genet (2000) 2.83
Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. J Immunol (1988) 2.82
Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med (1993) 2.80
Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation (1980) 2.72
The association of education with coronary heart disease mortality in the USSR Lipid Research Clinics Study. Int J Epidemiol (1993) 2.69
A novel measure of genetic distance for highly polymorphic tandem repeat loci. Mol Biol Evol (1995) 2.65
Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet (2000) 2.62
Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore) (1993) 2.59
Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55
Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res (2000) 2.53
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation (1999) 2.39
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb (1992) 2.31
Rapid identification of Candida albicans septicemia in man by gas-liquid chromatography. J Clin Invest (1974) 2.29
Digital imaging fluorescence microscopy: spatial heterogeneity of photobleaching rate constants in individual cells. J Cell Biol (1985) 2.20
Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc (2001) 2.19
Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant. J Immunol (1973) 2.18
Body mass index and body girths as predictors of mortality in black and white women. Arch Intern Med (1992) 2.17
Feature (gene) selection in gene expression-based tumor classification. Mol Genet Metab (2001) 2.08
Bilateral gracilis neosphincter construction for treatment of faecal incontinence. Br J Surg (1995) 2.07
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation (1986) 2.06
Lipoprotein structure and metabolism. Physiol Rev (1976) 2.04
Homology between clindamycin resistance plasmids in Bacteroides. Plasmid (1984) 2.00
The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet (1991) 1.88
Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian Lipid Research Clinics Prevalence Follow-up Study. Circulation (1993) 1.86
A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood (2001) 1.86
Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation (1999) 1.81
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry (1973) 1.81
Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission. Am J Epidemiol (1982) 1.81
High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. Hum Mutat (2001) 1.80
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet (2001) 1.79
Lipoproteins: structure and function. Annu Rev Biochem (1975) 1.76
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res (2001) 1.74
Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men. N Engl J Med (1980) 1.72
Hypertension and subclinical carotid artery atherosclerosis in blacks and whites. The Atherosclerosis Risk in Communities Study. ARIC Investigators. Arch Intern Med (1996) 1.71
Introduction to the plasma lipoproteins. Methods Enzymol (1986) 1.71
Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. JAMA (1994) 1.70
Anticipation in myotonic dystrophy. I. Statistical verification based on clinical and haplotype findings. Neurology (1992) 1.70
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest (1978) 1.69
Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation (2001) 1.69
Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles (Indian Ocean). Int J Epidemiol (1999) 1.68
Human plasma lipoprotein [a]. Structural properties. J Biol Chem (1983) 1.68
Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest (1991) 1.68
Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect Immun (1983) 1.68
Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry (1975) 1.66
Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation (1998) 1.65
Bias of the contribution of single-locus effects to the variance of a quantitative trait. Am J Hum Genet (1986) 1.65
Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae. J Infect Dis (1980) 1.64
Cladistic structure within the human Lipoprotein lipase gene and its implications for phenotypic association studies. Genetics (2000) 1.64
Neural substrates of facial emotion processing using fMRI. Brain Res Cogn Brain Res (2001) 1.61
Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method. Clin Chem (1989) 1.60
Guidelines for quality assurance in multicenter trials: a position paper. Control Clin Trials (1998) 1.60
Analysis of sugars in bacterial endotoxins by gas-liquid chromatography. Anal Biochem (1969) 1.60
Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet (1991) 1.59
Simple method for culturing anaerobes. Appl Microbiol (1973) 1.58
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res (2000) 1.57
The evolution of r factor. A study of a "preantibiotic" community in Borneo. N Engl J Med (1970) 1.56
Verification of the Acute Physiology and Chronic Health Evaluation scoring system in a Hong Kong intensive care unit. Crit Care Med (1993) 1.55
APOE genotype and cognitive decline in a middle-aged cohort. Neurology (2005) 1.54
The plasma lipoproteins: structure and metabolism. Annu Rev Biochem (1978) 1.54
Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics (1999) 1.53
Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health (1988) 1.53
Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A (1978) 1.53
AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol (1995) 1.52
The primary structure of human apolipoprotein A-IV. Biochim Biophys Acta (1989) 1.50
The relationship between lipids/lipoproteins and atherosclerosis in African Americans and whites: the Atherosclerosis Risk in Communities Study. Ann Epidemiol (1999) 1.50
Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest (1983) 1.48